While everyone’s chasing flashy startups and tech hype, one pharma company is quietly rewriting the rules—and crushing it with ₹108 crore in revenue just three years after launch.
Meet Aqualab, the retail arm of Laborate Pharmaceuticals, that’s not just hitting numbers but dominating tier-II and tier-III towns where most big pharma players don’t even try.
From ₹76 Crore to ₹108 Crore in Just One Year — And The Real Boom Is Yet To Come
In FY 2022–23, Aqualab made ₹76 crore. By FY 2023–24, it smashed past ₹100 crore to ₹108 crore.
What’s next?
They’re aiming to more than double that to ₹250 crore by 2026 — with 42% of growth coming from non-metro India.
This is no ordinary growth story. It’s a playbook for how pharma will explode across India’s heartland.
How Did They Do It? Simple: Go Where Others Don’t
Here’s the secret sauce:
- A massive portfolio of 800+ products
- A network of 500+ retail stockists
- Laser focus on last-mile delivery to smaller towns and rural markets
Aqualab is proving that India’s real growth is beyond big cities, where affordability and accessibility matter most.
“Non-Metro Markets Will Drive Our Future” — And Investors Are Taking Note
Arpit Bhatia, Managing Director of Laborate, says:
“The Direct-to-Retail model is scaling fast. By FY 25–26, non-metro areas will fuel 42% of our growth. We’re expanding therapy categories and boosting last-mile reach.”
With India’s retail pharma market set to hit ₹31,200 crore by 2032, Aqualab is perfectly positioned to ride this massive wave.
Quality + Scale = Winning Formula
Behind the scenes, Aqualab’s secret weapon is its world-class manufacturing—WHO, GMP, and EU GMP certified facilities that keep quality high and costs low.
That means medicines that are affordable, reliable, and trusted in small towns as much as metros.
What’s Next? Bigger, Faster, Smarter
The company plans to:
- Launch new product categories
- Expand manufacturing capacity
- Embrace digital sales channels
- Explore exports
The goal? To become the #1 retail pharma powerhouse in India — and beyond.
Final Thought
Forget the usual startup hype. This pharma brand is quietly winning India’s health game where it matters most—right at the doorstep of millions in small towns.
With numbers like this and a bold vision, Aqualab isn’t just growing — it’s about to take over the entire retail pharma space.
Keep your eyes on this one. The next ₹250 crore might come faster than you think.
